Alpha Teknova (TKNO) Amortization of Deferred Charges (2021 - 2026)
Alpha Teknova's (TKNO) quarterly Amortization of Deferred Charges came in at $47000.0 in Q1 2026, down 45.35% year-on-year from $86000.0 in Q1 2025, and little changed on a QoQ basis from $47000.0 in Q4 2025.
Alpha Teknova (TKNO) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 6 years of Amortization of Deferred Charges data on file, last reported at $47000.0 in Q1 2026.
- On a quarterly basis, Amortization of Deferred Charges fell 45.35% year-over-year to $47000.0 in Q1 2026; TTM through Mar 2026 was $181000.0, a 54.29% decrease from a year earlier, with the FY2025 full-year figure at $220000.0, down 44.16% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $47000.0, roughly flat from $47000.0 in the prior quarter.
- Over the last five years, Amortization of Deferred Charges for TKNO reached as high as $205000.0 in Q3 2023 and fell as low as $43000.0 in Q2 2025.
- Historically, Amortization of Deferred Charges has averaged $84529.4 across 5 years, with a median of $84000.0 in 2024.
- Across the five-year window, Amortization of Deferred Charges soared 241.67% in 2023 and tumbled 58.65% in 2025, its largest moves.
- Year by year, Amortization of Deferred Charges stood at $119000.0 in 2022, then tumbled by 30.25% to $83000.0 in 2023, then advanced by 24.1% to $103000.0 in 2024, then tumbled by 54.37% to $47000.0 in 2025, then changed by 0.0% to $47000.0 in 2026.
- Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $47000.0 in Q1 2026, $47000.0 in Q4 2025, and $44000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47,000.00 |
| Mar 31, 2026 | 47,000.00 |
| Dec 31, 2025 | 47,000.00 |
| Dec 31, 2025 | 47,000.00 |
| Sep 30, 2025 | 44,000.00 |
| Sep 30, 2025 | 44,000.00 |
| Jun 30, 2025 | 43,000.00 |
| Jun 30, 2025 | 43,000.00 |
| Mar 31, 2025 | 86,000.00 |
| Mar 31, 2025 | 86,000.00 |
| Dec 31, 2024 | 103,000.00 |
| Dec 31, 2024 | 103,000.00 |
| Sep 30, 2024 | 103,000.00 |
| Sep 30, 2024 | 103,000.00 |
| Jun 30, 2024 | 104,000.00 |
| Jun 30, 2024 | 104,000.00 |
| Mar 31, 2024 | 84,000.00 |
| Mar 31, 2024 | 84,000.00 |
| Dec 31, 2023 | 83,000.00 |
| Dec 31, 2023 | 83,000.00 |